23andMe (NASDAQ:ME) Issues Earnings Results

23andMe (NASDAQ:ME) released its quarterly earnings data on Tuesday. The company reported ($1.02) earnings per share (EPS) for the quarter, Zacks reports. 23andMe had a negative net margin of 318.39% and a negative return on equity of 129.98%.

23andMe Stock Performance

Shares of ME stock traded up $0.05 during trading hours on Tuesday, reaching $3.40. The company had a trading volume of 138,534 shares, compared to its average volume of 192,537. The business has a fifty day moving average price of $3.46 and a 200-day moving average price of $5.41. 23andMe has a one year low of $2.65 and a one year high of $16.52. The firm has a market cap of $88.81 million, a PE ratio of -0.13 and a beta of 1.14.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 23andMe in a research note on Saturday, January 18th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.